00656.HK --


More News

  • Fosun successfully issued EUR500 million senior bond


    On 23 June 2021, Fosun International Limited (“Fosun” or the “Company”) successfully priced EUR500 million 5.25-year senior bond with coupon rate of 3.95% (the “Notes”).

  • Guo Guangchang: Good News for Cancer Patients! China's first Fosun Kite CAR-T cell therapy product, Yescarta®, approved for marketing


    Good news came from the National Medical Products Administration on June 23 —Fosun Kite's CAR-T cell therapy product, an axicabtagene ciloleucel injection, has been officially approved for marketing.It was almost 12 o'clock the night when this news was announced, so, first of all, I would like to pay my respects to the leaders and staff of the Nat

  • The first high-speed railway majority-owned by private investors in China completed


    In the morning on 22 June 2021, a group of construction workers were toiling at the construction site of the Wenling Station (溫嶺站), the terminal of the first high-speed railway that is majority-owned by private investors in China—the Hangzhou-Shaoxing-Taizhou Railway.

  • China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)


    SHANGHAI, June 24, 2021-- On June 23, 2021, Fosun Kite Biotechnology announced its autologous CD19-directed CAR-T cell therapy Axicabtagene Ciloleucel (FKC876) (axicabtagene ciloleucel) has been approved by China National Medical Products Administration (NMPA) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (r/r LBCL) after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma (PMBCL), high-grade B-cell lymphoma and DLBCL arising from follicular lymphoma[1].

  • China and India Combat Coronavirus Pandemic Together,Online Ceremony Held for the Handover of Medical Supplies to Aid India


    On 11 June 2021, an online ceremony was held for the handover of anti-pandemic supplies to aid India. Medical supplies to India included 135 oxygen concentrators, 5 ventilators and 3,300 KN95 masks. Present at the event were Tang Guocai, Chinese Consul General in Mumbai; Wang Yifei, Fosun Global Partner, Co-CEO of Fosun Hive, and Chief Representative of Fosun India; Dr. G.H. Fernandes, President of India-China Friendship Association; Mr. Suresh Deora, Chairman of Mumbai Red Cross Society, and representatives of hospitals which were beneficiaries.